CELU

Celularity Inc

Healthcare · Biotechnology

$121.87 sample

+0.47 (+0.39%) 1D

Market cap

$780.4B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-15

Alerts

8

Price$121.87 +10.11% 3M daily closessample

123.81108.46

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09INSInsider sell: 10% owner
Sep 30INSInsider sell: EVP, Operations
Sep 24INSInsider sell: Chief Financial Officer
Sep 15SECForm 144 filed
Sep 10INSInsider sell: Director
Sep 04INSInsider sell: Chief Executive Officer
Aug 27SEC8-K filed: material event
Aug 18INSInsider sell: EVP, Operations

Sign up to see the real CELU record →

Company facts

SEC EDGAR registration

Name: Celularity Inc
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -15sample, -100 to +100
Reporting currency: USD

Who is positioning in CELU

sample

Insiders: 11 insider transactions over 90 days, net selling, $128.9M
Congress: No member trades over 90 days
Institutions · 13F: 14 funds hold $5.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$24.4B +21.5% y/y

Q4 2024Q3 2026

Inventory$14.7B +11.2% y/y

Q4 2024Q3 2026

Accounts receivable$10.7B +8.0% y/y

Q4 2024Q3 2026

Total debt$27.6B +11.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $733.2B +0.1% 3M
Sample peer B: $682.4B +13.3% 3M
Sample peer C: $473.8B -5.1% 3M
Sample peer D: $308.3B -12.4% 3M
Sample peer E: $169.8B -6.4% 3M